Invention Grant
- Patent Title: Melanocortin receptor ligands
-
Application No.: US15587426Application Date: 2017-05-05
-
Publication No.: US09850280B2Publication Date: 2017-12-26
- Inventor: Zheng Xin Dong , Jacques-Pierre Moreau
- Applicant: Ipsen Pharma S.A.S.
- Applicant Address: FR Boulogne-Billancourt
- Assignee: Ipsen Pharma S.A.S.
- Current Assignee: Ipsen Pharma S.A.S.
- Current Assignee Address: FR Boulogne-Billancourt
- Agency: Ipsen Bioscience, Inc.
- Agent Eileen J. Ennis
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C07K7/00 ; C07K7/06
Abstract:
The present invention is directed to compounds according to formula, (R2R3)-A1-c(A2-A3-A4-A5-A6-A7-A8-A9)-A10-R1, and pharmaceutically-acceptable salts thereof that act as ligands for one or more of the melanocortin receptors, to methods of using such compounds to treat mammals and to pharmaceutical compositions comprising said compounds.
Public/Granted literature
- US20170240595A1 Melanocortin Receptor Ligands Public/Granted day:2017-08-24
Information query
IPC分类:
